-
Select Subcommittee Uncovers Trump White House’s Extreme Pressure Campaigns Targeting FDA’s Coronavirus Response
The report is the second to reveal the Select Subcommittee’s findings from its investigation into the Trump Administration’s political interference with the federal coronavirus response. -
Chairs Clyburn, Maloney Reveal That Quality Failures By Emergent BioSolutions Rendered 135 Million Additional Coronavirus Vaccine Doses Unusable
The rejection of the additional 135 million doses brings the total number of doses wasted due to Emergent BioSolutions’ failure to meet or maintain quality standards to over 525 million. -
Select Subcommittee Reveals Corporate Landlords Used Abusive Tactics To Evict Struggling Americans During Height Of Pandemic
The investigation revealed that four corporate landlords filed a total of 14,744 eviction actions between March 15, 2020, and July 29, 2021—nearly three times more than previously known. -
Select Subcommittee Report Reveals Full Scope Of Trump Admin's Embrace Of A Dangerous, Discredited Herd Immunity Via Mass Infection Strategy
The embrace of this strategy enabled Trump Admin officials to justify forgoing meaningful action to curb the spread of the virus when no vaccines were available and treatments were limited, likely contributing to many preventable deaths in the fall and winter of 2020-2021. -
Committees’ Report On Emergent BioSolutions Uncovers Extensive Vaccine Manufacturing Failures, Deliberate Efforts To Hide Deficiencies
New evidence shows that nearly 400 million doses of coronavirus vaccines—significantly more than previously known—were destroyed because of Emergent’s failure to meet or maintain quality standards at its Bayview manufacturing facility.
Latest News
Sep
16
Press Release
Washington, D.C. (September 16, 2022) – On Wednesday, September 21, 2022, at 2:00 p.m. ET, the Select Subcommittee on the Coronavirus Crisis, chaired by Rep. James E. Clyburn, will hold a hybrid hearing on the impact of the coronavirus in our nation’s nursing homes. Witnesses will include nursing home experts, an advocate, and a frontline worker who will testify to the challenges that the coronavirus pandemic has posed to nursing home residents and staff and what measures can be adopted to ensure nursing homes are better equipped to protect residents and staff in the future.
Sep
09
Press Release
Washington, D.C. (Sept. 9, 2022) — Rep. Carolyn B. Maloney, Chairwoman of the Committee on Oversight and Reform, and Rep. James E. Clyburn, Chairman of the Select Subcommittee on the Coronavirus Crisis, sent a letter to Mr. Richard K. Delmar, Deputy Inspector General of the Department of the Treasury, requesting a thorough review of the federal funding Treasury disbursed to airlines to sustain their operations during the coronavirus pandemic, including whether any funds were used for buyouts or staff reductions.
Aug
31
Press Release
Washington, D.C. (August 31, 2022) – Today, Rep. James E. Clyburn, Chairman of the Select Subcommittee on the Coronavirus Crisis, issued the following statement after the Food and Drug Administration’s (FDA) authorized Moderna and Pfizer-BioNTech single dose bivalent coronavirus vaccines for use as a booster at least two months following primary or booster vaccination.
Report Waste, Fraud, or Abuse
Chairman Clyburn is interested in any information regarding the waste, fraud, and abuse of taxpayer dollars. We respect your need to remain confidential and will use your contact information only to follow up with you regarding your submission.